✦ LIBER ✦

Emergence of HIV-1 Drug Resistance During Antiretroviral Treatment

✍ Scribed by Libin Rong; Zhilan Feng; Alan S. Perelson

Publisher: Springer
Year: 2007
Tongue: English
Weight: 691 KB
Volume: 69
Category: Article
ISSN: 1522-9602
DOI: 10.1007/s11538-007-9203-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiretroviral drug resistance among HIV

Antiretroviral drug resistance among HIV-1 infected children failing treatment

✍ Jane Mullen; Susan Leech; Siobhan O'Shea; Ian L. Chrystie; Gillian du Mont; Coli 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract High levels of HIV‐1 replication occur following perinatal infection and antiretroviral drugs may not fully suppress viral load during the early years of childhood. Adherence to treatment may also be difficult among children. These two factors will contribute to development of drug resi

Recombination favors the evolution of dr

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

✍ Antonio Carvajal-Rodríguez; Keith A. Crandall; David Posada 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 568 KB

We studied the relationship between recombination and the fixation time of multiple drug resistance mutations after HIV-1 drug therapy, under a set of different realistic scenarios. We have generalized a previous model by Bretscher et al. [Bretscher, Althaus, Muller, Bonhoeffer, 2004. Recombination

Antiretroviral drug resistance and phylo

Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile

✍ Maritza Ríos; Elena Delgado; Lucía Pérez-Álvarez; Jorge Fernández; Paula Gálvez; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract This study reports the analysis of human immunodeficiency virus type 1 (HIV‐1) protease (PR) and reverse transcriptase (RT) coding sequences from 136 HIV‐1‐infected subjects from Chile, 66 (49%) of them under antiretroviral (ARV) treatment. The prevalence of mutations conferring high or

Genotypic tropism of antiretroviral-trea

Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1

✍ Milosz Parczewski; Magdalena Leszczyszyn-Pynka; Anna Urbanska; Dorota Bander; An 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

## Abstract CCR5 inhibitors remain an attractive antiretroviral treatment option for HIV‐infected patients; however, tropism testing should be utilized prior their introduction. This study analyzed genotypic HIV‐1 tropisms in patients with evidence of genotypic drug resistance to antiretroviral the

Profile of drug resistance mutations amo

Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy

✍ A. Jlizi; A. Ben Ammar El Gaaied; A. Slim; F. Tebourski; M. Ben Mamou; T. Ben Ch 📂 Article 📅 2008 🏛 Springer Vienna 🌐 English ⚖ 239 KB

Effect of introduction of highly active

Effect of introduction of highly active antiretroviral treatment and the changes in patterns of drug-resistant HIV-1 in Japan

✍ W. Sugiura 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 334 KB